Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Ранг среди акций #17186
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Цена акции
$2.17
Рыночная капитализация
$249.58M
Изменение (1 день)
-1.67%
Изменение (1 год)
96.34%
Страна
CA
Торговля Cardiol Therapeutics Inc. (CRDL)

Категория

История цены акций Cardiol Therapeutics Inc. (CRDL)
Наивысшая цена закрытия: $2.19 2026-09-01

Наименьшая цена закрытия: $3.27 2018-12-01
История цены акций Cardiol Therapeutics Inc. с 2018 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 17.15%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$171.67 -
DE
$165.17 31.41%
DE
$38.13 25.43%
JP
$21.28 19.62%
IN
$214.98 26.11%
CH